Northeastern partners on Boston’s new Alzheimer’s initiative

Alice Bonner, an asso­ciate pro­fessor of nursing at North­eastern and a national leader in Alzheimer’s dis­ease care research, will lead the university’s efforts as part of an ini­tia­tive aimed at pro­viding more sup­port ser­vices to people with Alzheimer’s and their fam­i­lies and raising aware­ness about the impor­tance of early detection.

Students get hands-​​on training in simulation lab

Since opening seven months ago, the Arnold S. Gold­stein Sim­u­la­tion Lab­o­ra­to­ries Suite in the Bouvé Col­lege of Health Sci­ences has helped pre­pare under­grad­u­ates for co-​​op and careers through prac­tical diag­nostic exercises.

Funding tips for startup ventures

Entre­pre­neurs looking to make an impact in the health sci­ences industry got advice on funding and net­working oppor­tu­ni­ties from experts in a panel dis­cus­sion last week at Northeastern.

Welcome to the genome era

Alan Guttmacher, director of the Eunice Kennedy Shriver National Insti­tute of Child Health and Human Devel­op­ment, dis­cussed the future impli­ca­tions of the Human Genome Project with a score of North­eastern stu­dents and researchers.

3Qs: The effect of antibiotic resistant bacteria

The Cen­ters for Dis­ease Con­trol and Pre­ven­tion recently released a new report on the impact of antibi­otic resis­tant bac­teria on national health. We asked assis­tant pro­fessor Betsy Hirsch to explain its sig­nif­i­cance and what it means for the public.

Real life is not a clinical trial

Phar­macy grad­uate Nick O’Donnell earned an award at the RISE:2013 expo this spring for his work inves­ti­gating the adverse effects of intra­venous sedatives.

Healthcare entrepreneurs share secrets to success

Leaders of flour­ishing health­care com­pa­nies shared their suc­cess sto­ries on Thursday evening at an annual event hosted by the Health Sci­ences Entre­pre­neurs, an alumni group ded­i­cated to fos­tering entre­pre­neur­ship in the health­care field.

Nasal treatment targets Parkinson’s disease at its roots

Phar­ma­ceu­tical sci­ences pro­fessor Bar­bara Waszczak and grad­uate stu­dent Brendan Harmon devised an intranasal gene therapy that tar­gets the under­lying cause of Parkinson’s dis­ease, not just its symptoms.